Stay updated on BI 695500 Clinical Trial in RA: Efficacy, PK, Safety
Sign up to get notified when there's something new on the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page.

Latest updates to the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new drug names, Rituxan® and MabThera®, and an EudraCT number, while significant trial objectives and detailed inclusion and exclusion criteria have been removed.SummaryDifference28%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to BI 695500 Clinical Trial in RA: Efficacy, PK, Safety
Enter your email address, and we'll notify you when there's something new on the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page.